Hepatology|A randomized, double-blind, phase 3, non-inferiority trial of pradefovir mesylate versus tenofovir disoproxil fumarate in Chinese patients with chronic hepatitis B
本文二维码
计量
- 文章访问数: 7
- HTML全文浏览量: 0
- PDF下载量: 0
- 被引次数: 0
| 引用本文: |
| Citation: |
本文二维码